| - GRCh37:
- Chr2:202074150
- GRCh38:
- Chr2:201209427
| CASP10 | Q360R, Q384R, Q427R | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jan 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082441
- GRCh38:
- Chr2:201217718
| CASP10 | P449A, P473A, P516A | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jan 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052409-202052542
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050501-202052542
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060545-202060691
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060680
- GRCh38:
- Chr2:201195957
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060602
- GRCh38:
- Chr2:201195879
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052465-202052466
- GRCh38:
- Chr2:201187742-201187743
| CASP10 | N130fs | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060577
- GRCh38:
- Chr2:201195854
| CASP10 | V197A | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074296
- GRCh38:
- Chr2:201209573
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073964
- GRCh38:
- Chr2:201209241
| CASP10 | Y365S, Y298S, Y322S | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070644
- GRCh38:
- Chr2:201205921
| CASP10 | M256fs | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060580
- GRCh38:
- Chr2:201195857
| CASP10 | T198K | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074009
- GRCh38:
- Chr2:201209286
| CASP10 | H313R, H337R, H380R | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073909
- GRCh38:
- Chr2:201209186
| CASP10 | D280N, D347N, D304N | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050826
- GRCh38:
- Chr2:201186103
| CASP10 | R109P | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057814
- GRCh38:
- Chr2:201193091
| CASP10 | N184fs | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074031
- GRCh38:
- Chr2:201209308
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050809
- GRCh38:
- Chr2:201186086
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050749
- GRCh38:
- Chr2:201186026
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070635
- GRCh38:
- Chr2:201205912
| CASP10 | L251P | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050858
- GRCh38:
- Chr2:201186135
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202068454
- GRCh38:
- Chr2:201203731
| CASP10 | Q229L | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052497
- GRCh38:
- Chr2:201187774
| CASP10 | K139T | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052500
- GRCh38:
- Chr2:201187777
| CASP10 | D140A | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057794
- GRCh38:
- Chr2:201193071
| CASP10 | V177I | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202072869
- GRCh38:
- Chr2:201208146
| CASP10 | L265F | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060644
- GRCh38:
- Chr2:201195921
| CASP10 | D219E | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060628
- GRCh38:
- Chr2:201195905
| CASP10 | L214R | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050863
- GRCh38:
- Chr2:201186140
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070602
- GRCh38:
- Chr2:201205879
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202068496
- GRCh38:
- Chr2:201203773
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jan 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082414
- GRCh38:
- Chr2:201217691
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074068
- GRCh38:
- Chr2:201209345
| CASP10 | A357T, A400T, A333T | Autoimmune lymphoproliferative syndrome type 2A, CASP10-related condition | Uncertain significance (Aug 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:202074003
- GRCh38:
- Chr2:201209280
| CASP10 | M378T, M335T, M311T | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060562
- GRCh38:
- Chr2:201195839
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052541
- GRCh38:
- Chr2:201187818
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057849
- GRCh38:
- Chr2:201193126
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082446
- GRCh38:
- Chr2:201217723
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202072782
- GRCh38:
- Chr2:201208059
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070699
- GRCh38:
- Chr2:201205976
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050711
- GRCh38:
- Chr2:201185988
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050751
- GRCh38:
- Chr2:201186028
| CASP10 | Y84C | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050760
- GRCh38:
- Chr2:201186037
| CASP10 | R87Q | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070671
- GRCh38:
- Chr2:201205948
| CASP10 | T263S | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057764
- GRCh38:
- Chr2:201193041
| CASP10 | L167V | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057809
- GRCh38:
- Chr2:201193086
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074069
- GRCh38:
- Chr2:201209346
| CASP10 | A333V, A357V, A400V | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050814
- GRCh38:
- Chr2:201186091
| CASP10 | L105Q | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050803
- GRCh38:
- Chr2:201186080
| CASP10 | E101D | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070628
- GRCh38:
- Chr2:201205905
| CASP10 | P249S | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060686
- GRCh38:
- Chr2:201195963
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060691
- GRCh38:
- Chr2:201195968
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074218
- GRCh38:
- Chr2:201209495
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074257
- GRCh38:
- Chr2:201209534
| CASP10 | C463S, C396S, C420S | Inborn genetic diseases, Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:202074179
- GRCh38:
- Chr2:201209456
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073956
- GRCh38:
- Chr2:201209233
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073938
- GRCh38:
- Chr2:201209215
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070626
- GRCh38:
- Chr2:201205903
| CASP10 | A248V | Autoimmune lymphoproliferative syndrome type 2A, Inborn genetic diseases | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:202060675
- GRCh38:
- Chr2:201195952
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060573-202060574
- GRCh38:
- Chr2:201195850-201195851
| CASP10 | I196fs | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074219
- GRCh38:
- Chr2:201209496
| CASP10 | R450Q, R407Q, R383Q | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Nov 16, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:202060571
- GRCh38:
- Chr2:201195848
| CASP10 | Q195R | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073794
- GRCh38:
- Chr2:201209071
| CASP10 | E241D, E265D, E308D | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074246
- GRCh38:
- Chr2:201209523
| CASP10 | I392S, I416S, I459S | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070674
- GRCh38:
- Chr2:201205951
| CASP10 | L264P | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082396
- GRCh38:
- Chr2:201217673
| CASP10 | Q435fs, Q459fs, Q502fs | Autoimmune lymphoproliferative syndrome type 2A | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082298
- GRCh38:
- Chr2:201217575
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074196
- GRCh38:
- Chr2:201209473
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050626
- GRCh38:
- Chr2:201185903
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Apr 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070588
- GRCh38:
- Chr2:201205865
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082368
- GRCh38:
- Chr2:201217645
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Apr 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073776
- GRCh38:
- Chr2:201209053
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050734
- GRCh38:
- Chr2:201186011
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057854
- GRCh38:
- Chr2:201193131
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052409-202052410
- GRCh38:
- Chr2:201187686-201187687
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073938
- GRCh38:
- Chr2:201209215
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Nov 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202057850
- GRCh38:
- Chr2:201193127
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073798
- GRCh38:
- Chr2:201209075
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jun 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060608
- GRCh38:
- Chr2:201195885
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082294
- GRCh38:
- Chr2:201217571
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073775
- GRCh38:
- Chr2:201209052
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202082307
- GRCh38:
- Chr2:201217584
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050590
- GRCh38:
- Chr2:201185867
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202072925
- GRCh38:
- Chr2:201208202
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073923
- GRCh38:
- Chr2:201209200
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074295-202074296
- GRCh38:
- Chr2:201209572-201209573
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Benign (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070590
- GRCh38:
- Chr2:201205867
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074265
- GRCh38:
- Chr2:201209542
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jun 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202073983
- GRCh38:
- Chr2:201209260
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202072789
- GRCh38:
- Chr2:201208066
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202072896
- GRCh38:
- Chr2:201208173
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Sep 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070705
- GRCh38:
- Chr2:201205982
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202052471
- GRCh38:
- Chr2:201187748
| CASP10 | | Autoimmune lymphoproliferative syndrome type 2A | Likely benign (Jul 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070659
- GRCh38:
- Chr2:201205936
| CASP10 | A259V | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Nov 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070666-202070667
- GRCh38:
- Chr2:201205943-201205944
| CASP10 | N262fs | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202070646
- GRCh38:
- Chr2:201205923
| CASP10 | G255R | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202050582
- GRCh38:
- Chr2:201185859
| CASP10 | D28H | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202060585
- GRCh38:
- Chr2:201195862
| CASP10 | P200S | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:202074225
- GRCh38:
- Chr2:201209502
| CASP10 | V452A, V385A, V409A | Autoimmune lymphoproliferative syndrome type 2A | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |